Free Trial
→ Former CIA to Trump – Will you Shut down this secret lab? (From Paradigm Press) (Ad) Free ADPT Stock Alerts

Adaptive Biotechnologies (ADPT) SEC Filings & 10K Form

Adaptive Biotechnologies logo
$7.49 +0.82 (+12.29%)
Closing price 03/11/2025 04:00 PM Eastern
Extended Trading
$7.72 +0.23 (+3.14%)
As of 06:24 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Adaptive Biotechnologies SEC Filings

Export to Excel
DateFilerForm TypeView
03/10/2025
1:48 PM		Adaptive Biotechnologies (Subject)
NEUPERT PETER M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
6:14 PM		Adaptive Biotechnologies (Issuer)
GRIFFIN MICHELLE RENEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:15 PM		Adaptive Biotechnologies (Issuer)
HERSHBERG ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:16 PM		Adaptive Biotechnologies (Issuer)
NEUPERT PETER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:16 PM		Adaptive Biotechnologies (Issuer)
OWEN KATEY EINTERZ (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:17 PM		Adaptive Biotechnologies (Issuer)
Pellini Michael J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:17 PM		Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:18 PM		Adaptive Biotechnologies (Issuer)
ROBINS HARLAN S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:19 PM		Adaptive Biotechnologies (Issuer)
RUBINSTEIN JULIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:20 PM		Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:21 PM		Adaptive Biotechnologies (Issuer)
BENZENO SHARON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:22 PM		Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:22 PM		Adaptive Biotechnologies (Issuer)
LO FRANCIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:10 PM		Adaptive Biotechnologies (Subject)
GRIFFIN MICHELLE RENEE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
3:36 PM		Adaptive Biotechnologies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2025
6:28 PM		Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:51 PM		Adaptive Biotechnologies (Subject)
ROBINS CHAD M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
7:21 PM		Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
10:23 AM		Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
Form SCHEDULE 13G/A
02/13/2025
4:11 PM		Adaptive Biotechnologies (Subject)
ROBINS CHAD M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
1:20 PM		Adaptive Biotechnologies (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SCHEDULE 13G/A
02/04/2025
5:13 AM		Adaptive Biotechnologies (Subject)
Sumitomo Mitsui Trust Group, Inc. (Filed by)
Form SCHEDULE 13G/A
01/27/2025
3:00 PM		Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SCHEDULE 13G/A
11/19/2024
5:45 PM		Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:30 PM		Adaptive Biotechnologies (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G
11/13/2024
8:00 AM		Adaptive Biotechnologies (Subject)
Matrix Capital Management Company, LP (Filed by)
Form SC 13G/A
11/12/2024
12:30 PM		Adaptive Biotechnologies (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
2:15 PM		Adaptive Biotechnologies (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G
11/07/2024
3:30 PM		Adaptive Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
5:07 AM		Adaptive Biotechnologies (Subject)
Sumitomo Mitsui Trust Group, Inc. (Filed by)
Form SC 13G
11/04/2024
9:58 AM		Adaptive Biotechnologies (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/11/2024
3:14 PM		Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G/A
10/10/2024
4:47 PM		Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:27 PM		Adaptive Biotechnologies (Issuer)
Taylor Stacy L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:18 PM		Adaptive Biotechnologies (Subject)
Taylor Stacy L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:30 PM		Adaptive Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
3:15 PM		Adaptive Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
3:22 PM		Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G
05/24/2024
11:01 AM		Adaptive Biotechnologies (Filer)
Form DEFA14A
05/17/2024
5:35 PM		Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
4:29 PM		Adaptive Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Musk’s real agenda in Washington… (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

Here’s the full story.
04/05/2024
3:30 PM		Adaptive Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
4:55 PM		Adaptive Biotechnologies (Issuer)
NEUPERT PETER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ADPT) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners
Former CIA to Trump – Will you Shut down this secret lab?
Deep in the sands of New Mexico lies a government lab so secret it makes Area 51 look like a tourist spot… ...
Paradigm Press | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...
Crypto Swap Profits | Sponsored
March 18th: Gold SHOCK?
On March 18th, an event is taking place that could completely shock the market. Stocks could go ballistic…...
InvestorPlace | Sponsored
Urgent Bitcoin alert for RIGHT NOW
Former billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...
Brownstone Research | Sponsored
Musk’s real agenda in Washington…
In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...
Porter & Company | Sponsored
DeFi Coin on Verge of Breakout!
We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years.
Crypto 101 Media | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored